Tapewire

Nasdaq · USD

RGNX

REGENXBIO Inc.

Export transactions ↓
Tapewire entity
2211
SEC CIK
0001590877
Parsed reports
367

Last 12 months

Inside the activity.

2 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202601
Apr 202600
May 202601
Jun 202601
Jul 202602
Aug 202620
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
January 02, 2024 Filed Jan 4, 2024 21:06 UTC
Christmas Patrick J.Chief Legal Officer
GrantStock Options (Right to buy) · Derivative 54,945 $0.00 Strike: $18.34 $0.00
Disclosure

SEC source: 0001562180-24-000219 · primarydocument.xml · derivative · entry 3

Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 54,945

Underlying: Common Stock · 54,945 shares

Expires 2034-01-02

F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2025 while the optionee provides continuous service to the Issuer.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:06 UTC
Christmas Patrick J.Chief Legal Officer
GrantCommon Stock 34,615 $0.00 $0.00
Disclosure

SEC source: 0001562180-24-000219 · primarydocument.xml · nonDerivative · entry 2

Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,759

F2 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2025, January 1, 2026, January 1, 2027 and January 1, 2028 while the recipient provides continuous service to the Issuer.

Read SEC document
January 02, 2024 Filed Jan 4, 2024 21:06 UTC
Christmas Patrick J.Chief Legal Officer
Tax withholdingCommon Stock 7,893 $17.95 $141,679.35
Disclosure

SEC source: 0001562180-24-000219 · primarydocument.xml · nonDerivative · entry 1

Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 81,144

F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022 and January 3, 2023. The number of shares withheld was determined on January 2, 2024 based on the closing price of the issuer's common stock on December 29, 2023.

Read SEC document
December 19, 2023 Filed Dec 21, 2023 18:38 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionStock Options (Right to Buy) · Derivative 1,500 $0.00 Strike: $0.85 $0.00
Disclosure

SEC source: 0001562180-23-008519 · primarydocument.xml · derivative · entry 5

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 36,316

Underlying: Common Stock · 1,500 shares

Expires 2024-09-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F4 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 1,500 shares, became exercisable as follows: 25% of the shares subject to this option vested on September 24, 2015, and the balance vested in equal monthly installments over the 36 months thereafter.

Read SEC document
December 19, 2023 Filed Dec 21, 2023 18:38 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionStock Options (Right to Buy) · Derivative 43,500 $0.00 Strike: $3.76 $0.00
Disclosure

SEC source: 0001562180-23-008519 · primarydocument.xml · derivative · entry 4

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 186,354

Underlying: Common Stock · 43,500 shares

Expires 2025-05-19

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 43,500 shares, became exercisable as follows: 25% of the shares subject to this option vested on May 9, 2016, and the balance vested in equal monthly installments over the 36 months thereafter.

Read SEC document
December 19, 2023 Filed Dec 21, 2023 18:38 UTC
Mills Kenneth T.Director · President and CEO
SaleCommon Stock 45,000 $19.69 $885,825.00
Disclosure

SEC source: 0001562180-23-008519 · primarydocument.xml · nonDerivative · entry 3

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 355,289

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $19.48 to $20.12. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
December 19, 2023 Filed Dec 21, 2023 18:38 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionCommon Stock 1,500 $0.85 $1,275.00
Disclosure

SEC source: 0001562180-23-008519 · primarydocument.xml · nonDerivative · entry 2

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 400,289

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
December 19, 2023 Filed Dec 21, 2023 18:38 UTC
Mills Kenneth T.Director · President and CEO
Exercise / conversionCommon Stock 43,500 $3.76 $163,560.00
Disclosure

SEC source: 0001562180-23-008519 · primarydocument.xml · nonDerivative · entry 1

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 398,789

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
June 30, 2023 Filed Jan 4, 2024 16:22 UTC
Danos OlivierChief Scientific Officer
GrantCommon Stock 1,123 $16.99 $19,081.45
Disclosure

SEC source: 0001562180-24-000249 · primarydocument.xml · nonDerivative · entry 2

Danos Olivier · CIK 0001701180 · Chief Scientific Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 94,801

F3 · security: The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the ESPP for the ESPP purchase period of January 1, 2023 through June 30, 2023. This transaction is exempt under Rule 16b-3(c).

F4 · price: In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on June 30, 2023.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 21:11 UTC
Bennett JeanDirector
GrantStock Options (Right to Buy) · Derivative 17,892 $0.00 Strike: $19.72 $0.00
Disclosure

SEC source: 0001562180-23-004889 · primarydocument.xml · derivative · entry 2

Bennett Jean · CIK 0001872219 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,892

Underlying: Common Stock · 17,892 shares

Expires 2033-06-02

F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 21:11 UTC
Bennett JeanDirector
GrantCommon Stock 3,486 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-004889 · primarydocument.xml · nonDerivative · entry 1

Bennett Jean · CIK 0001872219 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,496

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 21:12 UTC GrantStock Options (Right to Buy) · Derivative 17,892 $0.00 Strike: $19.72 $0.00
Disclosure

SEC source: 0001562180-23-004892 · primarydocument.xml · derivative · entry 2

MIGAUSKY GEORGE V · CIK 0001134365 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,892

Underlying: Common Stock · 17,892 shares

Expires 2033-06-02

F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 21:12 UTC GrantCommon Stock 3,486 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-004892 · primarydocument.xml · nonDerivative · entry 1

MIGAUSKY GEORGE V · CIK 0001134365 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,496

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 21:11 UTC GrantStock Options (Right to Buy) · Derivative 17,892 $0.00 Strike: $19.72 $0.00
Disclosure

SEC source: 0001562180-23-004888 · primarydocument.xml · derivative · entry 2

Zachary Jennifer · CIK 0001737231 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,892

Underlying: Common Stock · 17,892 shares

Expires 2033-06-02

F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 21:11 UTC GrantCommon Stock 3,486 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-004888 · primarydocument.xml · nonDerivative · entry 1

Zachary Jennifer · CIK 0001737231 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,506

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 21:12 UTC GrantStock Options (Right to Buy) · Derivative 17,892 $0.00 Strike: $19.72 $0.00
Disclosure

SEC source: 0001562180-23-004891 · primarydocument.xml · derivative · entry 2

Glucksmann Alexandra · CIK 0001658390 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,892

Underlying: Common Stock · 17,892 shares

Expires 2033-06-02

F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 21:12 UTC GrantCommon Stock 3,486 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-004891 · primarydocument.xml · nonDerivative · entry 1

Glucksmann Alexandra · CIK 0001658390 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,496

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 21:14 UTC
Fox Allan M.Director
GrantStock Options (Right to Buy) · Derivative 17,892 $0.00 Strike: $19.72 $0.00
Disclosure

SEC source: 0001562180-23-004896 · primarydocument.xml · derivative · entry 6

Fox Allan M. · CIK 0001652936 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,892

Underlying: Common Stock · 17,892 shares

Expires 2033-06-02

F3 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 21:14 UTC
Fox Allan M.Director
GrantCommon Stock 3,486 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-004896 · primarydocument.xml · nonDerivative · entry 1

Fox Allan M. · CIK 0001652936 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,496

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 21:12 UTC GrantStock Options (Right to Buy) · Derivative 17,892 $0.00 Strike: $19.72 $0.00
Disclosure

SEC source: 0001562180-23-004893 · primarydocument.xml · derivative · entry 2

STUMP DAVID C · CIK 0001191235 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,892

Underlying: Common Stock · 17,892 shares

Expires 2033-06-02

F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 21:12 UTC GrantCommon Stock 3,486 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-004893 · primarydocument.xml · nonDerivative · entry 1

STUMP DAVID C · CIK 0001191235 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,496

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 21:12 UTC GrantStock Options (Right to Buy) · Derivative 17,892 $0.00 Strike: $19.72 $0.00
Disclosure

SEC source: 0001562180-23-004890 · primarydocument.xml · derivative · entry 2

KARABELAS ARGERIS N · CIK 0001191229 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,892

Underlying: Common Stock · 17,892 shares

Expires 2033-06-02

F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 21:12 UTC GrantCommon Stock 3,486 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-004890 · primarydocument.xml · nonDerivative · entry 1

KARABELAS ARGERIS N · CIK 0001191229 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,496

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 21:13 UTC
Tasse DanielDirector
GrantStock Options (Right to Buy) · Derivative 17,892 $0.00 Strike: $19.72 $0.00
Disclosure

SEC source: 0001562180-23-004894 · primarydocument.xml · derivative · entry 2

Tasse Daniel · CIK 0001502785 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,892

Underlying: Common Stock · 17,892 shares

Expires 2033-06-02

F2 · derivative.exercise_date: The option will vest in 12 equal monthly installments following June 2, 2023 subject to the continuous service of the optionee to the Issuer.

Read SEC document
June 02, 2023 Filed Jun 6, 2023 21:13 UTC
Tasse DanielDirector
GrantCommon Stock 3,486 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-004894 · primarydocument.xml · nonDerivative · entry 1

Tasse Daniel · CIK 0001502785 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,496

F1 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 100% of the shares subject to this RSU will vest on June 1, 2024 subject to the continuous service of the recipient to the Issuer.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 16:12 UTC
Vasista VittalChief Financial Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 35,000 $0.00 Strike: $0.85 $0.00
Disclosure

SEC source: 0001562180-23-004722 · primarydocument.xml · derivative · entry 2

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 35,000 shares

Expires 2024-09-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The previously granted option, representing a right to purchase a total of 424,900 shares, became exercisable as follows: 284,683 of the shares subject to the option are initial shares ("Initial Shares") and 140,217 of the shares subject to the option are contingent shares ("Contingent Shares"). 72,235 of the Initial Shares vested on September 17, 2014, 53,112 of the Initial Shares vested on September 17, 2015 and an additional 4,426 of the Initial Shares vested upon each month of continuous service to the Company thereafter. 25% of the Contingent Shares were deemed vested as of September 17, 2014 on January 13, 2015 due to a subsequent event. The remainder of the Contingent Shares vested over four years of service following September 17, 2014, with 25% of the remaining 75% of Contingent Shares having vested on September 17, 2015 and the remaining Contingent Shares having vested in 36 equal monthly installments thereafter.

F2 · derivative.exercise_date: Notwithstanding the foregoing, 59,533 shares subject to this option that would otherwise have vested monthly between January 2018 and September 2018 were deemed vested as of December 31, 2015 on January 28, 2016 due to subsequent events.

Read SEC document
May 31, 2023 Filed Jun 2, 2023 16:12 UTC
Vasista VittalChief Financial Officer
Exercise / conversionCommon Stock 35,000 $0.85 $29,750.00
Disclosure

SEC source: 0001562180-23-004722 · primarydocument.xml · nonDerivative · entry 1

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 215,001

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:06 UTC
PAKOLA STEVEChief Medical Officer
GrantStock Options (Right to buy) · Derivative 44,155 $0.00 Strike: $22.25 $0.00
Disclosure

SEC source: 0001562180-23-000222 · primarydocument.xml · derivative · entry 4

PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 44,155

Underlying: Common Stock · 44,155 shares

Expires 2033-01-03

F5 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 48 months following January 3, 2024 while the optionee provides continuous service to the Issuer.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:06 UTC
PAKOLA STEVEChief Medical Officer
GrantCommon Stock 90,588 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-000222 · primarydocument.xml · nonDerivative · entry 3

PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 102,763

F4 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2024, January 1, 2025, January 1, 2026 and January 1, 2027 while the recipient provides continuous service to the Issuer.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:06 UTC
PAKOLA STEVEChief Medical Officer
SaleCommon Stock 3,138 $22.17 $69,559.42
Disclosure

SEC source: 0001562180-23-000222 · primarydocument.xml · nonDerivative · entry 2

PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,175

F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: This transaction was executed in multiple trades at prices ranging from $22.0000 to $22.3800. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:06 UTC
PAKOLA STEVEChief Medical Officer
Tax withholdingCommon Stock 1,837 $22.68 $41,663.16
Disclosure

SEC source: 0001562180-23-000222 · primarydocument.xml · nonDerivative · entry 1

PAKOLA STEVE · CIK 0001700659 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,313

F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021 and January 3, 2022. The number of shares withheld was determined on January 3, 2023 based on the closing price of the issuer's common stock on December 30, 2022.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 16:06 UTC
Danos OlivierChief Scientific Officer
GrantStock Options (Right to buy) · Derivative 52,986 $0.00 Strike: $22.25 $0.00
Disclosure

SEC source: 0001562180-23-000220 · primarydocument.xml · derivative · entry 3

Danos Olivier · CIK 0001701180 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,986

Underlying: Common Stock · 52,986 shares

Expires 2033-01-03

F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 48 months following January 3, 2024 while the optionee provides continuous service to the Issuer.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 16:06 UTC
Danos OlivierChief Scientific Officer
GrantCommon Stock 65,930 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-000220 · primarydocument.xml · nonDerivative · entry 2

Danos Olivier · CIK 0001701180 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,950

F2 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2024, January 1, 2025, January 1, 2026 and January 1, 2027 while the recipient provides continuous service to the Issuer.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 16:06 UTC
Danos OlivierChief Scientific Officer
Tax withholdingCommon Stock 2,058 $22.68 $46,675.44
Disclosure

SEC source: 0001562180-23-000220 · primarydocument.xml · nonDerivative · entry 1

Danos Olivier · CIK 0001701180 · Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,020

F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021 and January 3, 2022. The number of shares withheld was determined on January 3, 2023 based on the closing price of the issuer's common stock on December 30, 2022.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:06 UTC
Mills Kenneth T.Director · President and CEO
GrantStock Options (Right to buy) · Derivative 264,932 $0.00 Strike: $22.25 $0.00
Disclosure

SEC source: 0001562180-23-000221 · primarydocument.xml · derivative · entry 3

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 264,932

Underlying: Common Stock · 264,932 shares

Expires 2033-01-03

F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 48 months following January 3, 2024 while the optionee provides continuous service to the Issuer.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:06 UTC
Mills Kenneth T.Director · President and CEO
GrantCommon Stock 54,753 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-000221 · primarydocument.xml · nonDerivative · entry 2

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 355,289

F2 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2024, January 1, 2025, January 1, 2026 and January 1, 2027 while the recipient provides continuous service to the Issuer.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:06 UTC
Mills Kenneth T.Director · President and CEO
Tax withholdingCommon Stock 9,308 $22.68 $211,105.44
Disclosure

SEC source: 0001562180-23-000221 · primarydocument.xml · nonDerivative · entry 1

Mills Kenneth T. · CIK 0001652824 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 300,536

F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021 and January 3, 2022. The number of shares withheld was determined on January 3, 2023 based on the closing price of the issuer's common stock on December 30, 2022.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 16:06 UTC
Vasista VittalChief Financial Officer
GrantStock Options (Right to buy) · Derivative 66,233 $0.00 Strike: $22.25 $0.00
Disclosure

SEC source: 0001562180-23-000224 · primarydocument.xml · derivative · entry 3

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,233

Underlying: Common Stock · 66,233 shares

Expires 2033-01-03

F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 48 months following January 3, 2024 while the optionee provides continuous service to the Issuer.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 16:06 UTC
Vasista VittalChief Financial Officer
GrantCommon Stock 46,174 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-000224 · primarydocument.xml · nonDerivative · entry 2

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 180,001

F2 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2024, January 1, 2025, January 1, 2026 and January 1, 2027 while the recipient provides continuous service to the Issuer.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 16:06 UTC
Vasista VittalChief Financial Officer
Tax withholdingCommon Stock 1,333 $22.68 $30,232.44
Disclosure

SEC source: 0001562180-23-000224 · primarydocument.xml · nonDerivative · entry 1

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 133,827

F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021 and January 3, 2022. The number of shares withheld was determined on January 3, 2023 based on the closing price of the issuer's common stock on December 30, 2022.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:06 UTC
Simpson CurranChief Oper. & Tech. Officer
GrantStock Options (Right to buy) · Derivative 52,986 $0.00 Strike: $22.25 $0.00
Disclosure

SEC source: 0001562180-23-000223 · primarydocument.xml · derivative · entry 3

Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,986

Underlying: Common Stock · 52,986 shares

Expires 2033-01-03

F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 48 months following January 3, 2024 while the optionee provides continuous service to the Issuer.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:06 UTC
Simpson CurranChief Oper. & Tech. Officer
GrantCommon Stock 67,945 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-000223 · primarydocument.xml · nonDerivative · entry 2

Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,985

F2 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2024, January 1, 2025, January 1, 2026 and January 1, 2027 while the recipient provides continuous service to the Issuer.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:06 UTC
Simpson CurranChief Oper. & Tech. Officer
Tax withholdingCommon Stock 2,076 $22.68 $47,083.68
Disclosure

SEC source: 0001562180-23-000223 · primarydocument.xml · nonDerivative · entry 1

Simpson Curran · CIK 0001346164 · Chief Oper. & Tech. Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,040

F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021 and January 3, 2022. The number of shares withheld was determined on January 3, 2023 based on the closing price of the issuer's common stock on December 30, 2022.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:06 UTC
Christmas Patrick J.Chief Legal Officer
GrantStock Options (Right to buy) · Derivative 56,519 $0.00 Strike: $22.25 $0.00
Disclosure

SEC source: 0001562180-23-000219 · primarydocument.xml · derivative · entry 3

Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,519

Underlying: Common Stock · 56,519 shares

Expires 2033-01-03

F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 48 months following January 3, 2024 while the optionee provides continuous service to the Issuer.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:06 UTC
Christmas Patrick J.Chief Legal Officer
GrantCommon Stock 67,940 $0.00 $0.00
Disclosure

SEC source: 0001562180-23-000219 · primarydocument.xml · nonDerivative · entry 2

Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 89,037

F2 · shares: Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2024, January 1, 2025, January 1, 2026 and January 1, 2027 while the recipient provides continuous service to the Issuer.

Read SEC document
January 03, 2023 Filed Jan 5, 2023 21:06 UTC
Christmas Patrick J.Chief Legal Officer
Tax withholdingCommon Stock 1,843 $22.68 $41,799.24
Disclosure

SEC source: 0001562180-23-000219 · primarydocument.xml · nonDerivative · entry 1

Christmas Patrick J. · CIK 0001521123 · Chief Legal Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 21,097

F1 · shares: Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021 and January 3, 2022. The number of shares withheld was determined on January 3, 2023 based on the closing price of the issuer's common stock on December 30, 2022.

Read SEC document
August 30, 2022 Filed Aug 31, 2022 18:01 UTC
Vasista VittalChief Financial Officer
SaleCommon Stock 2,400 $30.24 $72,572.64
Disclosure

SEC source: 0001562180-22-006398 · primarydocument.xml · nonDerivative · entry 1

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135,160

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $30.04 to $30.63. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 05, 2022 Filed Aug 8, 2022 16:04 UTC
Vasista VittalChief Financial Officer
SaleCommon Stock 17,280 $35.19 $608,034.82
Disclosure

SEC source: 0001562180-22-005938 · primarydocument.xml · nonDerivative · entry 2

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 137,560

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $35.00 to $35.73. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 04, 2022 Filed Aug 8, 2022 16:04 UTC
Vasista VittalChief Financial Officer
SaleCommon Stock 400 $35.00 $14,000.00
Disclosure

SEC source: 0001562180-22-005938 · primarydocument.xml · nonDerivative · entry 1

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 154,840

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

Read SEC document
August 01, 2022 Filed Aug 3, 2022 17:26 UTC
Vasista VittalChief Financial Officer
SaleCommon Stock 2,400 $31.26 $75,012.00
Disclosure

SEC source: 0001562180-22-005876 · primarydocument.xml · nonDerivative · entry 1

Vasista Vittal · CIK 0001652827 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 155,240

F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: This transaction was executed in multiple trades at prices ranging from $30.85 to $31.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.